摘要
Approximately 350 million persons worldwide are chronically infected with hepatitis B which can result in cirrhosis, liver failure and hepatocellular carcinoma Currently 2 interferons and 5 nucleos(t)ide analogues have been approved for the treatment of chronic hepatitis B (CHB) This article discusses the mechanisms of action pharmacokinetics optimal dose clinical efficacy, and side effects of medications used for the treatment of CHB
- 出版日期2010-9